Results 61 to 70 of about 36,916 (167)

Systematic Mapping of Protein Interactions Underlying IL-2 Secretion in Human T Cells. [PDF]

Anal Chem
Shin S, Rocamora F, Lewis NE.
europepmc   +1 more source

Clinical, Dietary, Lifestyle and Genetic Factors Associated With Age at Onset of Esophageal Adenocarcinoma. [PDF]

United European Gastroenterol J
Koch V, Gockel I, Reingruber J, Kreuser N, Bigge J, Venerito M, Alakus H, May A, Gerges C, Thieme R, Heider D, Hillmer AM, Ebigbo A, Bruns CJ, Lang H, Messmann H, Rösch T, Wissniowski TT, Müller M, Denzer UW, Nöthen MM, Vieth M, Thrift AP, Maj C, Schumacher J.   +24 more
europepmc   +1 more source

Stability of proton pump inhibitors for use in hypersensitivity evaluation. [PDF]

J Allergy Clin Immunol Glob
Wanandy T, Handley SA, Patel RP, Anwar S, Le TA, Lau WY, Wiese MD.   +6 more
europepmc   +1 more source

Self-perceived learning outcomes of academic detailing discussing rational therapy with proton pump inhibitors among general practitioners in Norway. [PDF]

Scand J Prim Health Care
Schjøtt J, Riedel BM, Espnes KA.
europepmc   +1 more source

Editorial: PPI‐responsive oesophageal eosinophilia and long‐term PPI treatment [PDF]

Alimentary Pharmacology & Therapeutics, 2016
J A, Alexander, D A, Katzka
openaire   +2 more sources

Analysis of proton pump inhibitor-associated drug problems and contributing factors among hospitalized nephrology patients. [PDF]

Front Pharmacol
Song N, Zhang X, Han M, Guan Y.
europepmc   +1 more source

Disrupting the Undruggable: Emerging Modalities for Targeting Protein-Protein Interactions in Oncology. [PDF]

Biology (Basel)
El-Tanani M, Rabbani SA, Wali AF, El-Tanani Y, Sharma S.   +4 more
europepmc   +1 more source

The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patients. [PDF]

Ther Adv Drug Saf
Crucitta S, Cinacchi P, Bargagna I, Biondani P, Giontella E, Palleschi M, Omarini C, Belluzzi L, Angelini L, Meattini I, Visani L, Stucci S, Porta C, Fontana A, De Giorgi U, Fogli S, Danesi R, Del Re M.   +17 more
europepmc   +1 more source

Nonvariceal Upper GI Bleeding in Established Users of Proton-Pump Inhibitors: Higher Incidence But Better Outcomes. [PDF]

Clin Transl Gastroenterol
Taha AS, McCloskey C, Craigen T, Angerson WJ.   +3 more
europepmc   +1 more source

Erratum: Reply to "Comment on 'Evaluation of the Long-Term Administration of Proton Pump Inhibitors (PPIs) in the Mineral Nutrient's Bioavailability'". [PDF]

ACS Omega
de Brito AS, do Nascimento AN, Fonseca FLA, Fioroto AM, Petri G, do Nascimento RGV.   +5 more
europepmc   +1 more source